We’ve got some news
For press and media, contact us at contact@osarahealth.com.
-
Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.
Read Latest Press: Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.
As featured by
And more…
Press releases
-
New Program Sees Vast Improvement in Return-to-Work Outcomes After Cancer
-
CancerAid and MinterEllison Join Together to Support and Empower Employees and Their Families Affected by Cancer
-
CancerAid – supporting employees after a cancer diagnosis